BioCryst (BCRX) Moves Higher as WHO Calls H7N9 'Most Lethal' Bird Flu Strain
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BioCryst Pharmaceuticals (BCRX) Lower Despite Rise in Bird Flu Death Toll
April 22, 2013 11:12 AM EDTBioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is taking a breather despite news the China bird flu death toll has risen to 21.
Shares of BioCryst have surged 45 percent since the beginning of the month on the China bird flu outbreak.
Shares of BCRX last traded at $1.73, down 4.4 percent.... More
BioCryst (BCRX) Sees Upside; No Poultry Contact Reported in Large Amount of Bird Flu Cases
April 17, 2013 9:32 AM EDTBioCryst Pharma (Nasdaq: BCRX) is moving higher again Wednesday following reports that the bird flu might not even be transferred via the main culprit: birds.
The World Health Organization (WHO) said that a number of new cases tied... More
